PRISM (Paediatric clinical Research Infrastructure Service Model), a Horizon Europe-funded project (GA N101292607), has opened its Transnational Access call (TNA1) for paediatric multinational investigator-initiated clinical studies. Selected studies will receive coordinated, end-to-end trial management services across Europe and Canada, with a requested budget of up to 2 M€ for interventional studies or 1 M€ for observational studies.
The call is open to pragmatic randomised controlled trials and prospective observational cohorts in children from birth to 18 years, in all paediatric disease areas except oncology and rare diseases, recruiting in 3 to 6 countries.
Letters of Intent for the 1st stage can be submitted until 31 December 2026, 17:00 CET.
A webinar will take place to present the call in details & anwser all questions: 8 October 2026, 16:00 CEST (register)
Deadline: Letters of intent 31 December 2026